Drugs / Yangxue Qingnao pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04958512 | Aug 2017 → Jan 2018 | cerebrovascular disorder | Peking University Third Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yangxue Qingnao pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04958512 ↗ |
| Route | Oral | “orally for 6 months” NCT04958512 ↗ |